Long-Acting GLP-1 RAs Exenatide (Bydureon) In 1987, scientists discovered that GLP-1 promotes insulin secretion, and five years later, an entero-insulin analogue, Exendin-4, which is 53% homologous to GLP-1, was isolated from the saliva of the Mexican giant lizard, later known as exenatide, which has GLP-1 receptor agonist activity and a half-life of 2.4 hours
Further, CDC population data from 2023 show that, in 23 states, 35% of adults have obesitya striking increase over the past ten years
Beyond the brain, these medications perform a vital dual role in your metabolic system
While medications can target GLP-1 directly, supporting your bodys natural production through nutrition, movement and mindful habits is a sustainable and holistic approach